Shared decision making in primary malignant bone tumour surgery in children and young adults

Autor: Kiki Blom, Peter Bekkering, Marlieke Hagemeijer, Marta Fiocco, Gerard Schaap, Michiel van de Sande, Sander Dijkstra, Bart Schreuder, Ingrid van der Geest, Paul Jutte, Joris Ploegmakers, Hans Merks, Jos A.M. Bramer

Publikováno v: EJC Paediatric Oncology, Vol 3, Iss , Pp 100138- (2024)

Background: Children and young adults needing surgery for a primary malignant bone tumour around the knee face a difficult, life changing decision. This study describes the level of shared decision making (SDM) experienced and preferred by these pati

Externí odkaz: https://doaj.org/article/4c19eb1b8e5a4617bfbdc56994355b11

Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trial

Autor: Jeremy Whelan, Carlo Lancia, Jakob Anninga, Hans Gelderblom, Marta Fiocco, Audinga-Dea Hazewinkel, Michiel van de Sande

Publikováno v: BMJ Open, Vol 12, Iss 3 (2022)

Objectives Investigating the effect of prognostic factors in a multistate framework on survival in a large population of patients with osteosarcoma. Of interest is how prognostic factors affect different disease stages after surgery, with stages of l

Externí odkaz: https://doaj.org/article/77ce590c15754fbc9a46cd992679f379

Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour

Autor: Tatiana Georgiesh, Ninna Aggerholm-Pedersen, Patrick Schöffski, Yifan Zhang, Andrea Napolitano, Judith V. M. G. Bovée, Åse Hjelle, Gordon Tang, Mateusz Spalek, Margherita Nannini, David Swanson, Thomas Baad-Hansen, Raf Sciot, Asle C. Hesla, Paul Huang, Desiree Dorleijn, Hans Kristian Haugland, Maribel Lacambra, Jacek Skoczylas, Maria A. Pantaleo, Rick L. Haas, Leonardo A. Meza-Zepeda, Florian Haller, Anna M. Czarnecka, Herbert Loong, Nina L. Jebsen, Michiel van de Sande, Robin L. Jones, Felix Haglund, Iris Timmermans, Akmal Safwat, Bodil Bjerkehagen, Kjetil Boye

Publikováno v: British Journal of Cancer, 127(10), 1793-1798. SPRINGERNATURE
Georgiesh, T, Aggerholm-Pedersen, N, Schoffski, P, Zhang, Y, Napolitano, A, Bovee, J V M G, Hjelle, A, Tang, G, Spalek, M, Nannini, M, Swanson, D, Baad-Hansen, T, Sciot, R, Hesla, A C, Huang, P, Dorleijn, D, Haugland, H K, Lacambra, M, Skoczylas, J, Pantaleo, M A, Haas, R L, Meza-Zepeda, L A, Haller, F, Czarnecka, A M, Loong, H, Jebsen, N L, van de Sande, M, Jones, R L, Haglund, F, Timmermans, I, Safwat, A, Bjerkehagen, B & Boye, K 2022, ' Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour ', British Journal of Cancer, vol. 127, pp. 1793–1798 . https://doi.org/10.1038/s41416-022-01959-4

Background: Current risk models in solitary fibrous tumour (SFT) were developed using cohorts with short follow-up and cannot reliably identify low-risk patients. We recently developed a novel risk model (G-score) to account for both early and late r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd25bb81e20bc049c2f5369780ede4b8
https://doi.org/10.1038/s41416-022-01959-4

Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry : A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies

Autor: Emanuela Palmerini, John H Healey, Nicholas M Bernthal, Sebastian Bauer, Hendrik Schreuder, Andreas Leithner, Javier Martin-Broto, Francois Gouin, Julio Lopez-Bastida, Hans Gelderblom, Eric L Staals, Florence Mercier, Petra Laeis, Xin Ye, Michiel van de Sande

Publikováno v: The Oncologist. OXFORD UNIV PRESS
The Oncologist
The oncologist, vol 28, iss 6
Oncologist, 28, 6, pp. E425-E435

Background: The Tenosynovial giant cell tumor Observational Platform Project (TOPP) registry is an international prospective study that -previously described the impact of diffuse-type tenosynovial giant cell tumour (D-TGCT) on patient-reported outco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90f8e51bf78907075005958aff3cf4d2
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85162238029

Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches

Autor: Judith Bovee, Hans Gelderblom, Kirsten Van Langevelde, Michiel Van de Sande, Karoly Szuhai, Geert Spierenburg, Lizz Van der Heijden

Publikováno v: Expert Opinion on Therapeutic Targets, 26(4), 333-345. TAYLOR & FRANCIS LTD

Introduction Tenosynovial giant cell tumor (TGCT) is a mono-articular, benign or locally aggressive and often debilitating neoplasm. Systemic therapies are becoming part of the multimodal armamentarium when surgery alone will not confer improvements.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5aa66002c331fdb1023e4553bef5e6d
https://hdl.handle.net/1887/3455729